chrisvoncsefalvay/vaers-outcomes huggingface dataset:
17 weeks pregnant at the time of vaccination. Due August 23rd.   For about 24 hours, starting 14 hours post vaccination, I experienced muscle and joint pain, chills, fever, nausea, dizziness, vomiting, and diarrhea. I treated with tylenol. Symptoms went away within 24 hours of presenting.
Patient had initial onset of eczema in 2008. In the past, patient's eczema was generally limited to chest and back. Patient noted weeping eczema around one month after getting vaccine. Pt said it itched so much that eyes watered. There was oozing and bleeding, then scabbing. Patient first noted it on the arms. It quickly spread to rest of the body. Pt said that abdomen and posterior are less affected. Pt reported that this event has resulted in significant scarring that was not present in previous episodes of eczema. Patient has been managing it on her own due to experience with ineffective doctors in the past. For years, patient has been using eucalyptus lemon oil, coconut oil, teatree oil, peppermint oil, lavender to make her own lotions and spray. Patient started using the lotion and spray immediately after she noticed new eczema. Patient says that home remedies stop itching, but eczema is still present. Patient that she sometimes uses neosporin for sores on the back.
administered a dose of improperly stored; No adverse symptoms were reported.; This spontaneous report was received from a nurse practitioner and refers to a 2-year-old patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 03-JUN-2020, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) lot # reported as S007072 and expiration date was reported as 24-JAN-2022 (formulation, strength, dose, frequency, route of administration were not reported) for prophylaxis. Lot number S007072 is an invalid lot number for haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of above 47 degrees Fahrenheit for 10 minutes. Data logger was involved. There were no previous excursions reported. Action taken with the suspect vaccine and the outcome of the event was not reported.
no adverse reaction/no addtional AES; double dose of varicella given through concomitant administration of PROQUAD and VARIVAX to 1 year old patient.; This spontaneous report was received from a registered nurse, referring to a 1-year-old female patient. The patient's pertinent medical history, drug reactions/allergies and concomitant medication were not provided.      On 19-AUG-2022, double dose of varicella was given through concomitant administration of varicella virus vaccine live (oka/merck) (VARIVAX) (0.5ml/once, strength, route, lot# and expiration date were unknown) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (0.5ml/once, strength, route, lot# and expiration date were unknown) to the patient for prophylaxis (overdose). This was patient's first dose and that measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was injected into left arm and varicella virus vaccine live (oka/merck) (VARIVAX) was injected into right arm. No adverse reactions and product quality compliant were reported.
Information has been received from a woman in a pediatric office concerning a 27 month old white male who on 01Sep03 was vaccinated with a first IM dose of varicella virus vaccine live (lot 1158N). On 15Apr05 the pt was diagnosed with varicella. Subsequently, the pt recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional information is not expected.
Watery explosive diarrhea, severe abdominal cramping, abdominal pain, gas. 12/1/21 - 12/22/21. All tests negative. I lost 5 pounds. Resolved with diet: bananas, rice, applesauce, tea. Plain white chicken breast. Water. Probiotics
This spontaneous report as received from a Medical Assistant refers to a 6 months old female patient. The patient was vaccinated with her first dose of 0.2 ml, oral ROTATEQ (lot# reported as 0529aa, exp date 13-DEC-2012, oral) on 17-OCT-2012. On 27-DEC-2012 the patient was given an expired dose of ROTATEQ, oral (lot# reported as 0529aa, exp date 13-DEC-2012, the same lot as her first dose). No adverse effects reported. The outcome was unknown. Additional information has been requested.
Anaphylaxis. Flushing, hives, itching, eye swelling, cough, shortness of breath 1 hour after shot. Took albuterol, BENADRYL, improved gradually over approximately 6 hours.
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients with no demographic details. Medical history was not reported. Since an unknown date, an unknown number of patients were vaccinated with a VAQTA, (25/0.5 U/ml, 0.5 ml, intramuscular, lot #, expiration date and anatomical location not reported, frequency unspecified), which was not stored properly. No adverse effects were reported. Additional information has been requested.
chills, fatigue, headache, fever, aches and pains, dizzyness , nausea  all day, since the vaccination, all day the following day.... (today)
According to physician, pt received ZOSTAVAX 7/18/13. He had injection site redness and pain which progressed over a weeks time into full-blown shingles, which the physician treated him for.
weird pulsating in my legs and a little bit in my right arm,It felt like her blood or cells were clumping; thought i dislocated my arm,barely use my left arm yesterday; arm went into excruciating pain; nauseous; very light headed; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Mar-2021 and was forwarded to Moderna on 19-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (weird pulsating in my legs and a little bit in my right arm,It felt like her blood or cells were clumping), JOINT DISLOCATION (thought i dislocated my arm,barely use my left arm yesterday), DIZZINESS (very light headed), PAIN IN EXTREMITY (arm went into excruciating pain) and NAUSEA (nauseous) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038AZiA) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced DIZZINESS (very light headed) and NAUSEA (nauseous). On 17-Mar-2021, the patient experienced JOINT DISLOCATION (thought i dislocated my arm,barely use my left arm yesterday) and PAIN IN EXTREMITY (arm went into excruciating pain). On 18-Mar-2021, the patient experienced MUSCLE TWITCHING (weird pulsating in my legs and a little bit in my right arm,It felt like her blood or cells were clumping). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; CALCIUM CARBONATE (TUMS 500 CALCIUM) at a dose of 1 dosage form and IBUPROFEN (ADVIL 12 HOUR) at a dose of 1 dosage form. At the time of the report, MUSCLE TWITCHING (weird pulsating in my legs and a little bit in my right arm,It felt like her blood or cells were clumping), JOINT DISLOCATION (thought i dislocated my arm,barely use my left arm yesterday), DIZZINESS (very light headed), PAIN IN EXTREMITY (arm went into excruciating pain) and NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow up received on 1-07-2021 contains no newinformation.
Patient developed urticaria on her legs and torso within 1 hour of administration/ It should be noted that she had urticaria, although less severe, off and on for the week prior, on her arms only. Patient had no angioedema, dyspnea, dysphonia, or other evidence of more serious allergic reaction.
Red and itchy arm at site, traveled to shoulder to elbow; Red and itchy arm at site, traveled to shoulder to elbow; flu like; nausea; not eating; Headache; slept all day/ still tired; This is a spontaneous report received from contactable consumer. The reporter is the patient.  A 58-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the right arm, administration date 04Feb2021 11:30 (Lot number: EN5318) at the age of 58 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "multiple strokes" (unspecified if ongoing); "seizures" (unspecified if ongoing); "known allergies: penicillin" (unspecified if ongoing); "known allergies: all stone fruits and tree nuts" (unspecified if ongoing). Concomitant medications included: PLAVIX; LEVOTHYROXIN; LEVETIRACETAM; LIPITOR [ATORVASTATIN CALCIUM]. Vaccination history included: BNT162B2 (dose 1, administered in the right arm, Lot number: EL8982), administration date: 14Jan2021 11:30, when the patient was 58 years old, for COVID-19 immunisation. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE PRURITUS (non-serious) all with onset 07Feb2021 12:30, outcome "unknown" and all described as "red and itchy arm at site, traveled to shoulder to elbow"; INFLUENZA LIKE ILLNESS (non-serious) with onset 07Feb2021 12:30, outcome "unknown", described as "flu like"; NAUSEA (non-serious) with onset 07Feb2021 12:30, outcome "unknown", described as "nausea"; DECREASED APPETITE (non-serious) with onset 07Feb2021 12:30, outcome "unknown", described as "not eating"; HEADACHE (non-serious) with onset 07Feb2021 12:30, outcome "unknown", described as "headache"; FATIGUE (non-serious) with onset 07Feb2021 12:30, outcome "unknown", described as "slept all day/ still tired". The events "red and itchy arm at site, traveled to shoulder to elbow", "flu like", "nausea", "not eating", "headache" and "slept all day/ still tired" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of vaccination site erythema, vaccination site pruritus, influenza like illness, nausea, decreased appetite, headache, fatigue.  Additional information: Other concomitant medications included "vit." The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination, and she has not been tested for COVID-19 since the vaccination.  No follow up attempts are possible. No further information is expected.
6/28/05 Child awoke complaining of hot leg, tennis ball size knot R injection site. Redness became larger, extended from knee to hip. Some pain in foot. 6/29/05, size of mom's hand with increased redness to hip. Hot to touch. Denies fever, seizure. Used cool compress, Tylenol. Improved today with decreased redness.
Patient showed up with bruises on the injection site, and reported tenderness and hot. Patient appears to be alert, afebrile, and able to do daily activities. Counseled to monitor the adverse effects and report if it gets worse .
Itching in throat, dizzy BP 103/73, HR 72, RR 14.  VSS, water given, felt anixous.  Anxiety resolved and patient released from vaccination site.
GREEN OUT OF MY EYES; ALLERGY; This spontaneous report received from a patient concerned a 50 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: blurry eyes, and pollen allergy. The patient previously received with covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 04A21A, expiry: UNKNOWN) dose was not reported, 1 in total, administered on 02-APR-2021 for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient received additional dose of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 213D21A, and expiry: UNKNOWN) dose was not reported, 1 in total, administered on 02-DEC-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-MAY-2022, following vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced allergy (dose number in series 2) which lasted for one day but would still follow up with his doctor to make sure it was an actual allergy. On an unspecified date, the patient experienced green out of his eyes (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from allergy on 10-MAY-2022, and the outcome of green out of my eyes was not reported. This report was non-serious.
Customer received first dose Pfizer COVID vaccine and experienced some dizziness/lightheadedness and fast heartbeat after vaccination. He reported feeling dizzy about 5-10 minutes after vaccination . He also said he felt like his heart was beating faster. We called emergency services and while we were monitoring him and waiting for emergency services he said he was feeling better. Emergency services came and took him for evaluation.
Breakthrough COVID admission after being fully vaccinated.  Patient presented with progressively worsening cough, shortness of breath x 5 days, pleuritic chest pain, fevers.
I woke up to a rash on both arms. It was itchy, red and flared up when I scratched it. I took Benadryl at night and hydrocortisone and Benadryl itch cream in the evening. It went away in about 3 days.
Patient was administered monovalent for her booster on 09/01/2022 but according to guidelines should have received Bivalent at this time. Patient called to reschedule for the Bivalent and received the dose 11/03/2022.
Since approximately 9 pm of the same day received vaccines infant developed fussiness, high pitch crying, staring spells, twitching of lower extremities, fever of 98.7 and vomiting.
On 4/10/2021 I was at the vaccination site at 12:00PM when I started feeling uneasy, shortness of breath, turned into dizziness and completely felt unwell. The feeling made to produce some anxiety spells and it was very unpleasant. I then went to urgent care I seen DR and he confirmed that my throat was not swollen and it was not super dangerous at the time and be then prescribed me some anxiety medication called lorezapen. I have recieved a dose of the lorezapen at urgent care and later picked up medication from pharmacracy and on 04/11/2021 I felt better. I have never experienced anxiety before.
Rash lasted for twelve days. Less than 50 pox on body. No fever; seen by MD but only given Bacteroban to prevent skin infection.
Patient came to a COVID-19 Clinic hosted by Public Health on 11/4/2021. Patient was there to get the second dose (0.5ml) of a two dose series for the Moderna COVID-19 vaccine. Patient was inadvertently given a booster dose (0.25ml) instead of a full dose. The error was discovered after the clinic was over. The patient was called and notified that he received only half of the dose that he was expecting to receive. He was offered to return to the next clinic to receive a full dose. He stated that he was not interested in receiving another dose at this time. He denies any injury or poor outcome related to the vaccination.
Itchy eyes a few hours after injection. Several hours after injection I had hives on another part of my body not near the injection site. The next morning still had hives so I went to the ER. They told me to take Benadryl. I took 1, 25mg Benadryl and then took another 5 hours later. By the night/early morning the hives were gone. The injection site has a small bruise about the size of a dime. The nurse who gave the shot did so with a little more force than the other shots I received.
Patient was in a anaphylactic shock, SOB, hives, myalgia. Was given a dose of epinephrine and reaction was reversed.
Patient with painful itchy varicella rash times 24 hours, chills, muscle aches, afebrile. Skin with multiple stages of papules and pustules. Treated with Zovirax 800mg four times a day for 5 days, Calamine, Benadryl and Aveeno Oatmeal Baths.
Pt has lack of mobility in arm, went to Primary MD, got muscle relaxants, still no improvement.
On 8/28/99, the pt experienced conjunctivitis and presented to an ER. The reporting physician felt that the conjunctivitis was probably related to therapy with hepatitis B vax.
On May 11, 1999 thirteen days post vax with first dose, the pt developed approximately 50 generalized pruritics rash with multiple raised erythema papules on face, arms, legs, and trunk and temperature of 99F. Some of the rashes had tiny center blisters. The pt was seen by a physician on May 13, 1999 and was dx with vaccine related chickenpox. The MD felt that the pt's experience was an other medical event. It was noted that she was re-vaccinated on June 10 with vax that was improperly stored in fridge for unk period of time. The reporting physician believed there was an association between the pt's sx and vax.
Cold symptoms; Sinus pressure; congestion; dizziness; headache; positive Rapid COVID test; positive Rapid COVID test; booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 71-year-old female patient received bnt162b2 (BNT162B2), administration date 24Aug2021 (Batch/Lot number: unknown) at the age of 71 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing); "hypertension" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, (Name withheld) had a positive Rapid COVID test on 18Nov2021., She has Cold symptoms. Sinus pressure, congestion, headache, and dizziness.), for COVID-19 immunization, reaction(s): "positive Rapid COVID test"; Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization, reaction(s): "dizziness", "headache", "congestion", "Cold symptoms", "Sinus pressure", "positive Rapid COVID test"; Bnt162b2 (DOSE 2, SINGLE, (Name withheld) had a positive Rapid COVID test on 18Nov2021. She has Cold symptoms. Sinus pressure, congestion, headache, and dizziness.), for COVID-19 immunization, reaction(s): "positive Rapid COVID test"; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization, reaction(s): "dizziness", "headache", "congestion", "Cold symptoms", "Sinus pressure", "positive Rapid COVID test". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 18Nov2021, outcome "unknown" and all described as "positive Rapid COVID test"; IMMUNISATION (medically significant) with onset 24Aug2021, outcome "unknown", described as "booster"; NASOPHARYNGITIS (non-serious), outcome "unknown", described as "Cold symptoms"; PARANASAL SINUS DISCOMFORT (non-serious), outcome "unknown", described as "Sinus pressure"; NASAL CONGESTION (non-serious), outcome "unknown", described as "congestion"; DIZZINESS (non-serious), outcome "unknown", described as "dizziness"; HEADACHE (non-serious), outcome "unknown", described as "headache". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (18Nov2021) positive.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
BREAST FED BABY EXHIBITED SIGNS OF LETHARGY FOR ABOUT 12 HOURS. My baby slept, and slept, and slept, and slept. He was 3 months old, typically waking every 2 hours to feed still, he did not do this the night of my vaccine. I felt as if his body was also going through something. I exhibited fatigue, tinnitus, and a sore arm. All of it cleared. Dose 2 of Pfizer was taken 9/17/21. I experienced a DROP IN MILK SUPPLY 4 days post-second shot. I went from pumping 8 oz to 2 oz. There was no change in diet and no other medications taken during this time.
This spontaneous report was received from a physician via company representative and refers to a female patient of unknown age. No information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies were provided. On unknown date, the patient was vaccinated with GARDASIL 9 (lot number, expiration date, strength, dose number, route of administration and anatomical location were not provided) for human papilloma virus (HPV) prophylaxis. On unknown date, the patient experienced hives on an unspecified area of the body. The outcome of the event was reported as recovered. The causality assessment between the event and suspected therapy was not provided.
Pt taken to walk-in clinic on 07/14/02 described as + erythematous lesion everywhere with no excoriations. Recommended Tylenol only for comfort.
Received Pfizer vaccines on  4/14, 5/5 COVID-19 positive by PCR on 1/5/22 admitted to hospital 1/5-1/7/22 for work-up of new brain  tumor, found to be COVID positive on admit.
73 y.o. male who presents with hypoxia. Patient was noted to have low sats at the group home and was sent here. He denies any new symptoms. Sounded grumpy but would still answer questions. He thinks the group home has done a good job taking care of him. No chest pain, no nausea, no vomiting, no abdominal pain. Patient isn't currently hypoxic, saturating well on RA. Evaluation in ER revealed PE and he was given enoxaparin per my recommendation. Unfortunately group home was unable to take him back, hence the admission. He was just discharged yesterday after being hospitalized for COVID, he received remdesivir and dexamethasone up until he got discharged
Reports having a localized rash in lower torso/belly that is stretching to sides a bit. Patient describes appearance as "little red dots". Is there anything about rashes?; little red pimples; little red pimples; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Reports having a localized rash in lower torso/belly that is stretching to sides a bit. Patient describes appearance as "little red dots". Is there anything about rashes?), ACNE (little red pimples) and ERYTHEMA (little red pimples) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced ACNE (little red pimples) and ERYTHEMA (little red pimples). On 05-Feb-2021, the patient experienced RASH (Reports having a localized rash in lower torso/belly that is stretching to sides a bit. Patient describes appearance as "little red dots". Is there anything about rashes?). At the time of the report, RASH (Reports having a localized rash in lower torso/belly that is stretching to sides a bit. Patient describes appearance as "little red dots". Is there anything about rashes?), ACNE (little red pimples) and ERYTHEMA (little red pimples) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment details were provided.
Muscle, joint aches. Headache. Chills. Sore and red at injection site.  Still ongoing. Tylenol. Hot drinks.
Pt developed redness, warmth & swelling of left arm from injection site to elbow. Applied heat & seemed to improve.